Valneva IPO Presentation Deck
Valneva in Summary
We are a specialty vaccine company focused on the
development and commercialization of prophylactic
vaccines for infectious diseases with significant unmet
medical need
V
■ Highly specialized and targeted approach to development of unique prophylactic vaccines
■ Advanced pipeline of differentiated clinical-stage assets designed to address large target
populations
■ Product development and regulatory expertise with clear demonstrated ability of rapidly
moving new vaccines through the clinic to commercialization
Highly developed, nimble and sophisticated manufacturing infrastructure
■ Two commercialized vaccines, a specialist sales infrastructure and distribution rights for
third-party vaccines, which help to fund our clinical development efforts
Highly experienced leadership team with expertise in the vaccine space
Valneva - Roadshow Presentation
April 2021
5View entire presentation